Debut Biotech
Nicholas leads Debut’s molecular biology team and is an expert in biochemistry and small molecule biomanufacturing. Nicholas is an accomplished scientist with tenures at Cornell University, the University of Oxford, and the Salk Institute where he developed a new family of RNA-targeting CRISPR proteins. Nicholas has interest in developing and creating emerging technologies and the intersection of science and business.